课题基金 / 基金详情

Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy

Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
研究 GSTP1 作为乳腺癌中半胱氨酸氧化还原体的新型调节剂以及氧化还原治疗脆弱性的制造者
批准号:
10576645
负责人:
Jason M. Held
金额:
$18.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-12-12 至 2024-11-30

项目摘要

项目成果

Jason M. Held的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 谷胱甘肽S-转移酶Pi 1(GSTP 1)是一种将谷胱甘肽结合到小分子 亲电分子GSTP 1与促进许多癌症的生长有关 GSTP 1过表达促进代谢重新连接或隔离的类型 通过蛋白质-蛋白质相互作用的癌症相关信号蛋白。 与这些研究报道的癌症中GST 1的适度上调相反,我们的研究发现, 对癌细胞系、患者来源的异种移植物和患者肿瘤的系统评价发现, GSTP 1的表达在管腔内被独特地和显著地沉默了许多数量级。 乳腺癌,从最丰富的细胞蛋白之一到几乎不表达。Her2 阳性(Her 2+)乳腺癌具有双峰GSTP 1表达分布, 比例也沉默GSTP 1。 乳腺癌中GSTP 1表达的降低使我们发现了一种新的、非经典的 GSTP 1的调节功能:重新定向半胱氨酸氧化的通量,以在结构上重塑 蛋白质组通过变构二硫键。这些变化对乳腺癌至关重要 由于GST 1的再表达和氧化还原信号传导的抑制降低了转化, GSTP 1沉默的乳腺癌细胞的转化能力。 这项建议集中于两个具体目标。首先,GSTP 1沉默是一种治疗方法吗? BRCA的弱点?第二,什么是GST 1的分子和氧化还原体的后果 沉默总之,这些目标将提供新的机制洞察如何GST 1表达 驱动乳腺癌中的氧化还原信号传导,并确定GSTP 1沉默是否是治疗性的 可采取行动的脆弱性。
英文摘要
Project Summary Glutathione S-transferase Pi 1 (GSTP1) is an enzyme that conjugates glutathione to small molecule electrophiles. GSTP1 has been implicated in promoting the growth of many cancer types where GSTP1 overexpression is proposed to promote metabolic re-wiring or sequester cancer-related signaling proteins through protein-protein interactions. In contrast to the modest upregulation of GSTP1 in cancer reported by these studies, our systematic evaluation of cancer cell lines, patient-derived xenografts, and patient tumors finds that GSTP1 expression is uniquely and dramatically silenced by many orders of magnitude in luminal breast cancer, going from one of the most abundant cellular proteins to barely express. Her2 positive (Her2+) breast cancers have a bimodal GSTP1 expression distribution, with a significant proportion also silencing GSTP1. Decreased GSTP1 expression in breast cancer allowed us to discover a novel, non-canonical regulatory function of GSTP1: re-directing the flux of cysteine oxidation to structurally remodel the proteome via allosteric disulfide bonds. These changes are critical for breast cancer transformation since re-expression of GSTP1 and inhibition of redox signaling decreases the transformation capacity of GSTP1-silenced breast cancer cells. This proposal focuses on two Specific Aims. First, is GSTP1 silencing a therapeutic vulnerability in BRCA? Second, what are the molecular and redoxomic consequences of GSTP1 silencing? Together, these Aims will provide new mechanistic insight into how GSTP1 expression drives redox signaling in breast cancer and determine if GSTP1 silencing is a therapeutically actionable vulnerability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Optogenetics to Dissect the Role of Redox Signaling During C. Elegans Aging
  • 批准号:
    9751694
  • 项目类别:
  • 资助金额:
    $19.61万
  • 财政年份:
    2018
  • 负责人:
    Jason M. Held
  • 依托单位:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
  • 批准号:
    9283379
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2016
  • 负责人:
    Jason M. Held
  • 依托单位:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
  • 批准号:
    9175407
  • 项目类别:
  • 资助金额:
    $34.88万
  • 财政年份:
    2016
  • 负责人:
    Jason M. Held
  • 依托单位:
The role of p53 redox-modification in cell fate signaling
  • 批准号:
    8569469
  • 项目类别:
  • 资助金额:
    $20.48万
  • 财政年份:
    2013
  • 负责人:
    Jason M. Held
  • 依托单位:
海外基金